Conference Reports for NATAP
Back
 
13th Intl Workshop on Adverse
Reactions & Comorbidities in HIV
July 2011-Rome, Italy
Metabolic Risk Factors in Responders to Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, in HIV-Infected Patients with Excess Abdominal Fat
- (07/17/11)
 
Bone Mineral Density (BMD) Analysis in Antiretroviral (ART)-Naïve Subjects Taking Lopinavir/ritonavir (LPV/r) Combined with Raltegravir (RAL) or Tenofovir/Emtricitabine (TDF/FTC) for 96 weeks in the PROGRESS Study
- (07/17/11)